TrademarkDir
MTAC
LIVE

Serial Number

97813153

Owner

Avilar Therapeutics, Inc.

Attorney

Brent R. Bellows

First Use Date

May 4, 2024

Filing Date

Feb 27, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

MTAC Trademark

Serial Number: 97813153

MTAC is a trademark filed by Avilar Therapeutics, Inc. on February 27, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Avilar Therapeutics, Inc. (10 trademarks)

400 Totten Pond Road, Suite 110
Waltham, MA 02451

Entity Type: 03

Trademark Details

Filing Date

February 27, 2023

Registration Date

Not Registered

First Use Anywhere

May 4, 2024

First Use in Commerce

May 4, 2024

Published for Opposition

May 20, 2025

Goods & Services

Research and development in the field of pharmaceutical preparations that bind to mannose 6-phosphate (M6P) receptors

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 14, 2026 EXRA
SOU EXTENSION 1 GRANTED
Jan 13, 2026 EX1G
SOU EXTENSION 1 FILED
Jan 13, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 13, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 15, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 20, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 20, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 14, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 19, 2025 CNSA
ALLEGED AMENDMENT TO USE WITHDRAWN
Apr 19, 2025 AAUW
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 10, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 10, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 10, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 17, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 17, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 19, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 19, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 19, 2024 CNRT
USE AMENDMENT ACCEPTED
Sep 19, 2024 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Sep 18, 2024 AUPC
ASSIGNED TO LIE
Sep 18, 2024 ALIE
USE AMENDMENT FILED
May 6, 2024 IUAF
TEAS AMENDMENT OF USE RECEIVED
May 6, 2024 EAAU
TEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 6, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 26, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 26, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 30, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 30, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 30, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 28, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 18, 2023 NWOS
NEW APPLICATION ENTERED
Mar 2, 2023 NWAP

Related Trademarks

More from this Owner

AVITAC

AVITAC

AVILAR THERAPEUTICS

AVILAR THERAPEUTICS

XTAC

XTAC

AVITAC

AVITAC

XTAC

XTAC

XTAC

XTAC